Abstract:Background & objective: High grade serous ovarian cancer (HGSC) is the most lethal type of ovarian cancer malignancies. Around 50% of HGSCs are DNA-repair homologous recombination deficient (HRD) and 15% have CCNE1 gene amplification. Previous results have shown that tumor microenvironment (TME) can impact clinical prognosis in HGSC. In this study our objective was to characterize the interplay of the TME with HRD and CCNE1 amplification in HGSC and its association with clinical outcomes. Materials and methods: We collected TME spatial protein expression, genomics, and clinical data from 250 HGSC patients. We determined BRCA1/2 germline and somatic mutation status using targeted sequencing and promoter hyper-methylation. For the tumors without BRCA1/2 mutations, we performed shallow whole genome sequencing, and estimated the CCNE1 amplification and HRD status using shallowHRD and BRCAness copy number profiles. Immune cell infiltration was assessed also using IHC for CD8, CD20, CD68, and CD103. The single-cell spatial landscapes were analyzed for 1000 tumor cores from the tumor center and tumor periphery using cyclic immunofluorescence (tCycIF) imaging for 34 different protein markers. We categorized and spatially analyzed the single cells from the TME to distinct cellular subpopulations using the TRIBUS and scimap software. Results: In our study of the TME using highly multiplexed tissue imaging we identified a total of 4.8 million single cells of them 1.6 million were immune cells belonging to eight biological subpopulations. The immune cell proportion detected in each sample showed high concordance with the IHC estimation by a pathologist. Interestingly, the CD8+, CD20+, CD11c+, and CD15+ high immune cell infiltrations were higher in BRCA1/2 mutated as compared to the CCNE1 amplified tumors. High immune infiltration was associated with prolonged overall survival only in samples debulked before chemotherapy but not in samples debulked after chemotherapy. Using consensus clustering for cell protein expression and cell morphology, we identified five distinct tumoral and stromal cell clusters which showed significant heterogeneity among the tumor genotypes and association with clinical outcomes. Then, after clustering of the spatial single-cell proximity data, we identified 13 distinct recurrent cellular neighborhoods (RCNs). The two RCNs related to the tumor-stroma and tumor-immune interfaces exhibited the highest differences between HRD and CCNE1 samples. Finally, by using random forest machine learning classifiers of the cells and its neighborhoods, and using an approach to minimize overfitting, we were able to detect the features more representative in HRD samples, for example, MHC-I expression in cancer cells and in stromal cells. Conclusion: The integration of multi-omics data revealed distinct TMEs associated with HRD and clinical outcomes; this has the potential to be used to discover biomarkers for precision oncology in HGSCs. Citation Format: Fernando Perez-Villatoro, Lilian van Wagensveld, Aleksandra Shabanova, Siamak Hajizadeh, Julia Casado, Ella Anttila, Maaike A. van der Aa, Roy F.P.M. Kruitwagen, Gabe S. Sonke, Koen K. Van de Vijver, Peter K. Sorger, Hugo M. Horlings, Anniina Färkkilä. A spatially resolved single-cell tumor microenvironment of clinicomolecular subtypes of high-grade serous ovarian cancer [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2) nr B073.

Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Abstract 6065: Patterns of Dysregulated Coding and Noncoding Gene Expression in High-Grade Serous Ovarian Carcinomas

Identification and Molecular Characterization of a New Ovarian Cancer Susceptibility Locus at 17Q21.31.

Abstract 5479: Spatially resolved molecular features in the tumor-immune microenvironment of germline BRCA1/2 mutated versus BRCA wild type high grade serous ovarian cancers

Abstract 1562: Germline Polymorphisms in Cancer Stem Cell Genes Associate with Survival among Women with High-Grade Serous Ovarian Cancer

Abstract B083: Single-cell and spatial transcriptomic characterization of treatment resistance and immune dynamics in high-grade serous ovarian cancer

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma

Abstract B073: A spatially resolved single-cell tumor microenvironment of clinicomolecular subtypes of high-grade serous ovarian cancer

Single‐Cell RNA‐Sequencing Analysis Reveals Divergent Transcriptome Events between Platinum‐Sensitive and Platinum‐Resistant High‐Grade Serous Ovarian Carcinoma

Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade serous carcinoma using single-cell RNA sequencing and GEO gene expression signatures

Identification of estrogen response-associated STRA6+ granulosa cells within high-grade serous ovarian carcinoma by single-cell sequencing

Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites

Abstract 1513: A multi-sample study reveals the evolution and heterogeneity in high-grade serous ovarian cancer

Abstract A049: Fallopian tubes of BRCA carriers are characterized by an alteration of epithelial differentiation

Single-cell Transcriptomics Reveals the Aggressive Landscape of High-Grade Serous Carcinoma and Therapeutic Targets in Tumor Microenvironment

Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations

Comparative Analysis Between High-Grade Serous Ovarian Cancer and Healthy Ovarian Tissues Using Single-Cell RNA Sequencing.

Abstract 7347: A transcriptome correlation network analysis of the high grade serous ovarian tumor immune microenvironment

ScHGSC-IGDC: Identifying genes with differential correlations of high-grade serous ovarian cancer based on single-cell RNA sequencing analysis